2014年以前の論文リスト

  • Okubo M et al. Serum apolipoprotein B-48 concentration is associated with a reduced estimated glomerular filtration rate and increased proteinuria.
    J Atheroscler Thromb. 2014;21(9):974-82
  • Masuda D et al. Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals.
    J Atheroscler Thromb. 2014;21(6):618-27
  • Nakaoka H et al. Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions.
    PLoS One. 2013;8(8):e70755
  • Kawase R et al. Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice.
    Cardiovasc Res. 2013;100(1):125-33
  • Yuasa-Kawase M et al. Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases.
    J Atheroscler Thromb. 2012;19(3):263-75
  • Inagaki M et al. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.
    J Atheroscler Thromb. 2012;19(7):643-56
  • Yuasa-Kawase M et al. Apolipoprotein B-48 to triglyceride ratio is a novel and useful marker for detection of type III hyperlipidemia after antihyperlipidemic intervention.
    J Atheroscler Thromb. 2012;19(9):862-71
  • Hanada H et al. Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism.
    Clin Chim Acta. 2012;413(1-2):160-5
  • Masuda D et al. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence.
    Eur J Clin Invest. 2012;42(9):992-9
  • Tsubakio-Yamamoto K et al. Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography.
    Metabolism. 2012;61(12):1763-70
  • Saga A et al. HMG-CoA reductase inhibitor augments the serum total cholesterol-lowering effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic homozygous Watanabe rabbits.
    Biochem Biophys Res Commun. 2011;412(1):50-4
  • Nakatani K et al. Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels.
    Atherosclerosis. 2011;218(1):226-32
  • Okura H et al. HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins.
    J Atheroscler Thromb. 2010;17(6):568-77
  • Sandoval JC et al. Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice.
    J Atheroscler Thromb. 2010;17(6):610-8
  • Masuda D et al. Chylomicron remnants are increased in the postprandial state in CD36 deficiency.
    J Lipid Res. 2009;50(5):999-1011
  • Yamashita S et al. Where are we with probucol: a new life for an old drug?
    Atherosclerosis. 2009;207(1):16-23
  • Tsubakio-Yamamoto K et al. Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages.
    Biochem Biophys Res Commun. 2008;375(3):390-4
  • Oku H et al. Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.
    FEBS Lett. 2007;581(26):5029-33
PageTop